UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative effects of teriparatide and risedronate in glucocorticoid‐induced osteoporosis in men: 18‐month results of the EuroGIOPs trial

Journal of bone and mineral research, 2013-06, Vol.28 (6), p.1355-1368

2013

Volltextzugriff (PDF)

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis

Rheumatology international, 2009-12, Vol.30 (2), p.213-221

2009

Volltextzugriff (PDF)

The effect of Vitamin D on falls and fractures

Scandinavian journal of clinical & laboratory investigation. Supplement, 2012-04, Vol.72 (S243), p.73-78

Ringe, Johann D.

2012

Volltextzugriff (PDF)

The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)

Endocrine, 2015-09, Vol.50 (1), p.12-26

2015

Volltextzugriff (PDF)

Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence

Journal of bone and mineral research, 2011-07, Vol.26 (7), p.1662-1669

2011

Volltextzugriff (PDF)

Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass

Rheumatology international, 2012, Vol.32 (1), p.207-215

2012

Volltextzugriff (PDF)

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

The journal of clinical endocrinology and metabolism, 2007-04, Vol.92 (4), p.1296-1304

2007

Volltextzugriff (PDF)

Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol

Rheumatology international, 2004-07, Vol.24 (4), p.189-197

2004

Volltextzugriff (PDF)

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

Rheumatology international, 2009, Vol.29 (3), p.311-315

2009

Volltextzugriff (PDF)

Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy

Journal of bone and mineral metabolism, 2006-01, Vol.24 (1), p.87-93

2006

Volltextzugriff (PDF)

An estimate of the survival benefit of improving vitamin D status in the adult German population

Dermato-endocrinology, 2009-11, Vol.1 (6), p.301-307

2009

Volltextzugriff (PDF)

Vitamin-D-Unterversorgung in Deutschland: Gefahr für erhöhte Morbidität und Mortalität?

MMW Fortschritte der Medizin, 2011, Vol.153 (Suppl 4), p.115-118

2011

Volltextzugriff (PDF)

Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat

Rheumatology international, 2010-05, Vol.30 (7), p.863-869

2010

Volltextzugriff (PDF)

Treatment of osteoporosis in men

The journal of men's health & gender, 2007-09, Vol.4 (3), p.326-333

Ringe, Johann D.

2007

Volltextzugriff (PDF)

Safety and tolerability of higher-dose intravenous bisphosphonates in metastatic breast cancer

Bone (New York, N.Y.), 2007-11, Vol.41 (5), p.S41-S41

Ringe, Johann D

2007

Volltextzugriff (PDF)

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: Results from the 24-week extension of a 15-week randomized, controlled trial

Bone (New York, N.Y.), 2009-04, Vol.44 (4), p.639-647

2009

Volltextzugriff (PDF)

Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses

Wiener Klinische Wochenschrift, 2012, Vol.124 (1-2), p.25-31

2012

Volltextzugriff (PDF)

Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates

Clinical rheumatology, 2007-04, Vol.26 (4), p.474-484

2007

Volltextzugriff (PDF)

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis

Journal of rheumatology. Supplement, 2005-09, Vol.76, p.33

2005

Volltextzugriff (PDF)

Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of Osteoporosis: Results of Two Quantitative Patient Research Studies

Drugs & aging, 2009-01, Vol.26 (3), p.241-253

2009

Volltextzugriff (PDF)

Zoledronic acid in the treatment of Paget's disease and other benign bone disorders

Expert review of endocrinology & metabolism, 2006-01, Vol.1 (1), p.15-24

Ringe, Johann D

2006

Volltextzugriff (PDF)

Efficacy of strontium ranelate on bone mineral density in men with osteoporosis

Arzneimittel-Forschung, 2010-01, Vol.60 (5), p.267-272

2010

Volltextzugriff (PDF)

Kalzium plus Vitamin D als Basistherapie bei Osteoporose: Nutzen oder Risiko?: Patienten, aber auch Ärzte sind verunsichert

Orthopädie & Rheuma, 2014-04, Vol.17 (2), p.30-34

2014

Volltextzugriff (PDF)

Questions on the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis

Rheumatology international, 2004-11, Vol.24 (6), p.370-370

Ringe, Johann D

2004

Volltextzugriff (PDF)

Importance of calcium co-medication in bisphosphonate therapy of osteoporosis : An approach to improving correct intake and drug adherence

Drugs & aging, 2006-01, Vol.23 (7), p.569-578

2006

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(56)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(44)
Deutsch
(16)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(31)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Female
(21)
Osteoporosis
(20)
Biological And Medical Sciences
(19)
Osteoporosis - Drug Therapy
(19)
Medical Sciences
(18)
Aged
(16)
Bone Density Conservation Agents - Therapeutic Use
(13)
Diseases Of The Osteoarticular System
(11)
Male
(11)
Middle Aged
(11)
Pharmacology. Drug Treatments
(11)
Osteoporosis. Osteomalacia. Paget Disease
(10)
Rheumatology
(10)
Medicine
(9)
Alfacalcidol
(8)
Bone Density Conservation Agents - Administration & Dosage
(8)
Medicine & Public Health
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Rheumatology International
(7)
Arzneimittel-Forschung
(6)
Mmw Fortschritte Der Medizin
(4)
Osteologie
(4)
Arthritis + Rheuma
(2)
Bmj
(2)
Bmj. British Medical Journal
(2)
Bone
(2)
Current Medical Research And Opinion
(2)
Drugs & Aging
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparative effects of teriparatide and risedronate in glucocorticoid‐induced osteoporosis in men: 18‐month results of the EuroGIOPs trial

Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis

The effect of Vitamin D on falls and fractures

The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF)

Bone turnover markers and bone mineral density response with risedronate therapy: Relationship with fracture risk and patient adherence

Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass

Effect of Monitoring Bone Turnover Markers on Persistence with Risedronate Treatment of Postmenopausal Osteoporosis

Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol

Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study

Rapid pain relief and remission of sternocostoclavicular hyperostosis after intravenous ibandronate therapy

An estimate of the survival benefit of improving vitamin D status in the adult German population

Vitamin-D-Unterversorgung in Deutschland: Gefahr für erhöhte Morbidität und Mortalität?

Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat

Treatment of osteoporosis in men

Safety and tolerability of higher-dose intravenous bisphosphonates in metastatic breast cancer

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: Results from the 24-week extension of a 15-week randomized, controlled trial

Use of OROS® hydromorphone in the treatment of osteoarthritis and osteoporosis: A pooled analysis of three non-interventional studies focusing on different starting doses

Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis

Value of a New Fixed-Combination Pack of Bisphosphonate, Calcium and Vitamin D in the Therapy of Osteoporosis: Results of Two Quantitative Patient Research Studies

Zoledronic acid in the treatment of Paget's disease and other benign bone disorders

Efficacy of strontium ranelate on bone mineral density in men with osteoporosis

Kalzium plus Vitamin D als Basistherapie bei Osteoporose: Nutzen oder Risiko?: Patienten, aber auch Ärzte sind verunsichert

Questions on the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis

Importance of calcium co-medication in bisphosphonate therapy of osteoporosis : An approach to improving correct intake and drug adherence

Suchergebnisse filtern